Results 151 to 160 of about 70,002 (313)
Assessment of active inflammation in juvenile dermatomyositis: a novel magnetic resonance imaging-based scoring system [PDF]
William R. Davis +5 more
openalex +1 more source
Evaluating heterogeneity in MDA‐5+ dermatomyositis through cluster analyses
Journal of the European Academy of Dermatology and Venereology, EarlyView.
David R. Pearson
wiley +1 more source
Abstract A 6.5‐year‐old, spayed, female dog presented in acute respiratory distress. On admission, the dog exhibited dyspnoea, bradycardia, cyanosis and gastrointestinal signs, requiring immediate intubation and mechanical ventilation. Diagnostic evaluation revealed reduced butyrylcholinesterase activity, non‐cardiogenic pulmonary oedema, elevated ...
Sarah Hefer +6 more
wiley +1 more source
Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis [PDF]
Corinna Preuße +14 more
openalex +1 more source
Pharmacogenomics of Thiopurine Drugs: A Bench‐To‐Bedside Success Story in Thailand
ABSTRACT Thiopurine drugs are the cornerstone treatment for many diseases such as acute lymphoblastic leukemia (ALL), organ rejection, inflammatory bowel disease (IBD), systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and other autoimmune diseases.
Mohitosh Biswas +3 more
wiley +1 more source
Why do patients with myositis die? A retrospective analysis of a single-centre cohort [PDF]
OBJECTIVES: Causes of death in inflammatory myopathies have rarely been studied. We have assessed a cohort of myositis patients followed in a single centre over a 37-year period, reviewing the mortality rate, causes of death and predictors of poor ...
Cogollo, E, Isenberg, DA, Silva, MA
core
Abstract Objectives Anti‐MDA5 dermatomyositis (anti‐MDA5 DM) is the most severe subtype of dermatomyositis, due to its pulmonary involvement. Current treatment involves corticosteroids and immunosuppressants, but variability in responses exists. This study aims to evaluate the efficacy and safety of Janus kinase (JAK)– and calcineurin–inhibitor ...
Valentine Pagis +47 more
wiley +1 more source
Rapidly progressing treatment resistant anti-TIF1 gamma antibody positive dermatomyositis
Nidin Mohan +4 more
openalex +2 more sources
Juvenile dermatomyositis shows characteristic skin lesions. However, this does not rule out co‐occurring other autoimmune diseases, which may be more prominent regarding skin manifestations.
Aleksander Markovic +3 more
doaj +1 more source
Rituximab in the treatment of inflammatory myopathies: a review [PDF]
Several uncontrolled studies have encouraged the use of rituximab (RTX) in patients with myositis. Unfortunately, the first placebo-phase trial to assess the efficacy of RTX in refractory myositis did not show a significant difference between the two ...
Fasano, S +4 more
core

